Laboratory of Pediatric and Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
Department of Basic Sciences, College of Veterinary Medicine, Mississippi State University.
Clin Infect Dis. 2018 Oct 30;67(10):1523-1532. doi: 10.1093/cid/ciy327.
Reduced seasonal influenza vaccine effectiveness (VE) was observed in individuals who received repeated annual vaccinations. Preexisting influenza antibody levels were also found inversely correlated with postvaccination titers. These reports suggest that preexisting immunity may affect contemporary seasonal vaccine performance.
Influenza A/H3 specific cross-reactivity of postvaccination sera from humans with or without preexisting immunity was assessed by hemagglutination inhibition (HAI) assay. Ferret antisera induced by repeated H3 exposures were also subjected to HAI, antibody affinity, and antibody avidity analyses.
Human postvaccination sera derived from subjects with or without preexisting immunity showed different cross-reactivity against H3 variant viruses. Similarly, the breadth of cross-reactive ferret antibodies induced by repeated H3 exposures was also broadened. Antigenic differences between H3 viruses characterized by ferret antisera became smaller as the number of exposures increased. Although repeated H3 exposures induced "original antigenic sin" phenomena in HAI titers against later exposed viruses, resultant ferret antibodies showed gradually enhanced avidity for different H3/hemagglutinin. Increased antibody avidity was found to be inversely correlated with decreased antigenic differences among H3 viruses characterized.
Our results suggest that repeated H3 exposures imprinted not only antibody quantity but also antibody quality. The "naive" ferret model currently used for vaccine strain selection does not recapitulate the complexity of human preexisting immunity. Vaccine strains identified hereby may not provide coverage sufficient for those who were frequently infected and/or vaccinated, leading to the reduced VE observed.
在接受重复年度接种的人群中,观察到季节性流感疫苗效力(VE)降低。预先存在的流感抗体水平也被发现与接种后滴度呈反比。这些报告表明,预先存在的免疫可能会影响当代季节性疫苗的性能。
通过血凝抑制(HAI)测定评估了具有或不具有预先存在免疫的人类接种后血清中流感 A/H3 特异性交叉反应性。还对通过重复 H3 暴露诱导的雪貂抗血清进行了 HAI、抗体亲和力和抗体亲合力分析。
来自具有或不具有预先存在免疫的受试者的人类接种后血清对 H3 变异病毒显示出不同的交叉反应性。同样,通过重复 H3 暴露诱导的交叉反应性雪貂抗体的广度也扩大了。随着暴露次数的增加,H3 病毒之间的抗原差异变得更小,由雪貂抗血清所描述的。尽管重复 H3 暴露在针对后来暴露的病毒的 HAI 滴度中引起了“原始抗原性偏差”现象,但产生的雪貂抗体对不同的 H3/血凝素表现出逐渐增强的亲合力。发现增加的抗体亲合力与所描述的 H3 病毒之间的抗原差异降低呈负相关。
我们的结果表明,重复的 H3 暴露不仅印记了抗体数量,而且还印记了抗体质量。目前用于疫苗株选择的“幼稚”雪貂模型不能重现人类预先存在免疫的复杂性。通过这种方式鉴定的疫苗株可能无法为那些经常感染和/或接种疫苗的人提供足够的覆盖,从而导致观察到的 VE 降低。